Does THC Improve Athletic Performance? The Evidence (2026)

The Headline Finding: THC Is Not Ergogenic Strong evidence

Across four decades of laboratory studies in healthy adults, the peer-reviewed evidence consistently shows that acute THC exposure does not enhance — and may modestly impair — aerobic and anaerobic athletic performance. The Burr & Cheung systematic review for the Gatorade Sports Science Institute (Sports Science Exchange #218, 2021) put it in plain terms: no quality evidence supports ergogenic claims for THC. The Doping Authority Netherlands has gone further publicly, stating that cannabinoids "most likely have a negative impact on athletic performance" — a finding that directly contests the WADA "performance enhancement" rationale for the in-competition ban (see WADA cannabis rules).

Acute Aerobic and Endurance Findings

The classic study is Renaud and Cormier (Medicine & Science in Sports & Exercise, 1986). Twelve healthy young men cycled to exhaustion 10 minutes after smoking a 1.7%-THC cigarette. The findings were specific and consistent:

• Pre-exercise heart rate rose from 94 bpm to 119 bpm — a substantial tachycardia at rest.
• Peak VO2, peak VCO2, and peak heart rate were essentially unchanged.
• Time to exhaustion fell from 16.1 to 15.1 minutes — a reduction of roughly 6%.
• Bronchodilation was observed, with FEV1 rising from 4.28 L to 4.43 L.

Earlier work by Steadward and Singh (Medicine and Science in Sports, 1975) and Avakian et al. (Aviation, Space, and Environmental Medicine, 1979) reported similar patterns: heart-rate elevation at submaximal workloads, no ergogenic benefit, and reduced exercise economy. The more recent Ewell et al. (Sports Medicine, 2023) trial of 10 mg ingested THC in habitual users found "neither ergogenic nor ergolytic" effect on cycle ergometry — suggesting that tolerance dampens both directions of effect for habitual users at moderate edible doses.

Acute Anaerobic, Strength, and Reaction Time

Reaction time and complex motor tasks — driving simulators, hand-eye coordination tests, choice-reaction tasks — reliably degrade after acute THC exposure. Isometric strength is largely unaffected. Ware et al. (JAMA Internal Medicine, 2011) and the systematic reviews by Lisano et al. (Substance Use & Misuse, 2019, 2020) — covering chronic-use effects in athletes — found no chronic-use effect on VO2max, anaerobic power, testosterone, or cortisol. The combined picture: cannabis is not a strength suppressor, but it is a coordination and reaction-time impairer in the acute window, which matters more for tactical and skill-dependent sports than for raw isometric tasks.

The Bronchodilation Question

THC produces acute, modest bronchodilation. Tashkin et al. (American Review of Respiratory Disease, 1973) documented the effect peaking around 15 minutes post-inhalation and resolving within 60 minutes. The effect is not clinically asthmatic-grade — it is much smaller than that of prescribed beta-2 agonists like albuterol — and is offset by the airway irritation associated with chronic combustion smoking, as documented in Pletcher et al. (JAMA, 2012). The practical implication: THC bronchodilation is too small and too short-lived to function as a performance aid in any structured competition; clinically valid asthma management requires prescribed inhalers, not cannabis.

The Cardiac Cost

The most consistent acute physiological signal across nearly every study of cannabis and exercise is elevated heart rate at rest and at submaximal workloads. Renaud and Cormier observed a 25 bpm pre-exercise increase. This effect is the most plausible mechanism for the modest reduction in time-to-exhaustion observed across studies: at any given submaximal workload, THC raises cardiac stress without raising power output, increasing perceived exertion and shortening the duration the athlete can sustain the effort. For athletes with undiagnosed cardiac disease or hypertension, the acute-tachycardia effect is also a non-trivial safety consideration, as flagged by general-population cannabis cardiovascular reviews.

Bottom Line: Mildly Ergolytic, Probably Worth Avoiding Pre-Competition

The accumulated evidence does not support cannabis as a performance aid in any sport that has been studied. It produces small but consistent ergolytic effects (reduced time-to-exhaustion, elevated submaximal heart rate, impaired reaction time and coordination) and no ergogenic effects on VO2max, strength, anaerobic power, or hormonal profile. The Burr & Cheung 2021 GSSI review remains the cleanest summary: athletes considering pre-competition use should expect no performance benefit and a meaningful probability of small performance decrement.

The evidence-based use cases for cannabis in athletics — to the extent any exist — are post-competition and out-of-season: sleep onset, anxiolysis at moderate CBD doses, possibly pain and inflammation. Those are covered on CBD and athletes, recovery and sleep, and pain and inflammation. The takeaway here is narrower: do not expect THC to make you a better athlete on race day.